THE INDIAN PHARMACIST Official Circular Pharmacy Logo THE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
MEDICINE MONOGRAPH CODE: [8.5] ID: TIP-MED-000133

Cefuroxime Axetil

Active Ingredient / Scientific Identity: Cefuroxime Axetil • Class: Second-Generation Oral Cephalosporin Beta-Lactam Antibiotic (Lipophilic Ester Prodrug; WHO 'Watch' Group)

⚖️ Compare Profile
Generic / Entity NameCefuroxime Axetil ([8.5])
Verified Indian Brands / RefMonocef (Aristo), Oframax (Sun Pharma)
Pharmacological ClassSecond-Generation Oral Cephalosporin Beta-Lactam Antibiotic (Lipophilic Ester Prodrug; WHO
Available Dosage FormsOral Film-Coated Tablets: 125 mg, 250 mg, 500 mg; Paediatric Dry Syrup: 125 mg/5 mL; Parenteral (Cefuroxime So
Regulatory ClassificationSchedule H Prescription Drug (To be sold by retail on the prescription of a Registere
Key Warning & Review DateRenal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer s
Reviewed: 2026-11-10
Safety Matrix:⚖️ Legal Status: Schedule H Prescription Drug (To be sold by retail o✔️ Standard Clinical Dispensing Precautions

1. Clinical & Scientific Overview

Cefuroxime Axetil (TIP-MED-000133, Reference Code [8.5]) is classified under Antimicrobials — Antibacterial & Antibiotic Agents (Ch 08) as a Second-Generation Oral Cephalosporin Beta-Lactam Antibiotic (Lipophilic Ester Prodrug; WHO 'Watch' Group). Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).

Verified Indian Market Examples / Compendial Status:
Monocef (Aristo), Oframax (Sun Pharma)
Representative Indian Market Examples (Edition 2.7 Ch 08 [8.5], p. 95): Ceftum (GSK), Cetil (Lupin), Pulmocef (Micro Labs), Ceroxim (Ranbaxy/Sun), Zocef (Alkem), Altacef — Strengths & Dosage Forms: Oral Film-Coated Tablets: 125 mg, 250 mg, 500 mg; Paediatric Dry Syrup: 125 mg/5 mL; Parenteral (Cefuroxime Sodium): 750 mg, 1.5 g vials
Dosage Forms & Available Strengths:
Oral Film-Coated Tablets: 125 mg, 250 mg, 500 mg; Paediatric Dry Syrup: 125 mg/5 mL; Parenteral (Cefuroxime Sodium): 750 mg, 1.5 g vials
Routes: Oral / Parenteral / Topical as specified by formulation

3. Mechanism of Action & Pharmacodynamics

Second-Generation Oral Cephalosporin Beta-Lactam Antibiotic (Lipophilic Ester Prodrug; WHO 'Watch' Group) acting on target receptor/enzyme pathways in Antimicrobials — Antibacterial & Antibiotic Agents (Ch 08): clinical efficacy is mediated via Second-Generation Oral Cephalosporin Beta-Lactam Antibiotic (Lipophilic Ester Prodrug; WHO 'Watch' Group) for Community-acquired respiratory tract infections (acute bacterial sinusitis, otitis media, AECOPD, pneumonia), uncomplicated urinary tract infections, and skin and soft-tissue infections (unlike cefixime, second-generation cefuroxime retains good activity against methicillin-sensitive Staphylococcus aureus [MSSA] in cellulitis/wound infections and surgical prophylaxis)..

4. Therapeutic Indications & Evidence-Supported Uses

  • Community-acquired respiratory tract infections (acute bacterial sinusitis, otitis media, AECOPD, pneumonia), uncomplicated urinary tract infections, and skin and soft-tissue infections (unlike cefixime, second-generation cefuroxime retains good activity against methicillin-sensitive Staphylococcus aureus [MSSA] in cellulitis/wound infections and surgical prophylaxis)

🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.

5. Educational Dosage Context, Formulations & Administration

Educational Dosing & Regimen Summary: General Adult Reference: 250 mg to 500 mg twice daily (every 12 hours) for 5 to 10 days (250 mg BD for mild UTI/bronchitis; 500 mg BD for pneumonia, severe sinusitis, or skin/soft-tissue infections). Follow physician prescription.

Administration & Meal Timing: CRITICAL FOOD RULE: MUST be taken IMMEDIATELY AFTER FOOD! (Cefuroxime axetil is a lipophilic ester prodrug; taking it after a meal increases oral bioavailability from ~37% [fasting] up to ~52–60%!). Swallow the film-coated tablet whole—NEVER crush or chew! | Twice daily (every 12 hours, immediately after breakfast and dinner).

6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment

Absorption & Disposition:
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Metabolism & Biotransformation:
Renal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer standard individual dose once every 24 hours. • CrCl <10 mL/min: Administer once every 48 hours (with post-dialysis dose). Hepatic: Safe in liver disease.
Elimination & Renal Adjustment:
Renal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer standard individual dose once every 24 hours. • CrCl <10 mL/min: Administer once every 48 hours (with post-dialysis dose). Hepatic: Safe in liver disease.
Hepatic Impairment Considerations:
Renal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer standard individual dose once every 24 hours. • CrCl <10 mL/min: Administer once every 48 hours (with post-dialysis dose). Hepatic: Safe in liver disease.

7. Contraindications, Precautions & High-Risk Warnings

Contraindications & Red-Flag Precautions:
  • Contraindicated in cephalosporin allergy or severe immediate penicillin hypersensitivity. Caution in history of colitis.

Key Clinical Precautions: Renal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer standard individual dose once every 24 hours. • CrCl <10 mL/min: Administer once every 48 hours (with post-dialysis dose). Hepatic: Safe in liver disease.

8. Adverse Effects Profile

Common & Mechanism-Related Adverse Effects:
  • Nausea, diarrhoea, abdominal discomfort, intensely bitter lingering metallic aftertaste if tablet coat is broken, vaginal candidiasis, Jarisch-Herxheimer reaction (when treating Lyme disease).
  • Anaphylaxis, angioedema, C. difficile pseudomembranous colitis, SJS/TEN, haemolytic anaemia, cephalosporin-induced encephalopathy in unadjusted renal failure.
Serious / Dose-Limiting Adverse Effects:
  • Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.

9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions

  • Drugs that Raise Gastric pH (PPIs like Pantoprazole/Omeprazole, H2-blockers like Famotidine, and Antacids) significantly reduce the dissolution and bioavailability of Cefuroxime Axetil! Avoid co-administering antacids within 2 hours, and always take cefuroxime axetil with an acidic/full meal
  • Potentiates Warfarin INR
  • Probenecid increases cefuroxime AUC by 50%

10. Clinical Monitoring, Patient Counselling & Storage

Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.

Pharmacist Patient Counselling Points:

  • Patient Counselling Checklist: 2 Vital Counter Instructions for Ceftum/Zocef: (1) Always take immediately after breakfast and dinner—taking on an empty stomach wastes almost one-third of the medicine; (2) Swallow the tablet whole without crushing or breaking—crushed cefuroxime axetil is intensely, unbearably bitter (causes immediate gagging/vomiting) and absorbs poorly. If the patient takes an antacid, space it by at least 2 hours.
  • Meal & Clock Timing Instruction: CRITICAL FOOD RULE: MUST be taken IMMEDIATELY AFTER FOOD! (Cefuroxime axetil is a lipophilic ester prodrug; taking it after a meal increases oral bioavailability from ~37% [fasting] up to ~52–60%!). Swallow the film-coated tablet whole—NEVER crush or chew! (Twice daily (every 12 hours, immediately after breakfast and dinner).)
  • Missed Dose Protocol: Take with food as soon as remembered unless close to next scheduled dose.
  • Geriatric Dispensing Pearl: In elderly CGHS patients taking daily Pantoprazole/Omeprazole, taking Cefuroxime Axetil on an empty stomach leads to high rates of treatment failure due to high gastric pH—insist on taking it with a full meal and adjust to once daily if CrCl <30 mL/min.

Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Film-Coated Tablets: 125 mg, 250 mg, 500 mg; Paediatric Dry Syrup: 125 mg/5 mL; Parenteral (Cefuroxime Sodium): 750 mg, 1.5 g vials

11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)

THE 12-STEP ORAL DRUG JOURNEY THROUGH THE HUMAN BODY (LADME) Note: IV bolus enters Step 6 directly (F = 100%); Sublingual & Transdermal routes bypass Step 4–5 Portal First-Pass Metabolism 1. Oral Administration • Tablet / Capsule swallowed • Gastric emptying to duodenum pH 1.5–3.5 (Stomach) 2. Disintegration & Dissolution • Tablet breaks into granules • API dissolves in GI fluid Noyes-Whitney Dissolution Rate 3. GI Epithelial Absorption • Crosses intestinal villi • Passive / Active / P-gp efflux Small Intestine (Large Surface Area) 4. Portal Circulation • Mesenteric veins → Portal vein • Delivers blood to liver sinusoids Pre-systemic Venous Conduit 5. First-Pass Metabolism • Gut & hepatic CYP450 extraction • High: GTN, Propranolol, Morphine Determines Bioavailability (F = f_a × (1-E_H)) 6. Systemic Circulation • Hepatic vein → IVC → Heart • Unbound vs Albumin-bound drug Only FREE drug is active 7–8. Tissue Distribution (Vd) • Capillary permeation to organs • Blood-Brain & Placental barriers Vd = Dose / C_0 (L or L/kg) 9. Target Site of Action • Receptors (GPCR, Ion channel) • Enzymes & Carrier Transporters Pharmacodynamic Effect (E_max, EC50) 10. Hepatic Biotransformation • Phase I (CYP450 Oxidation/Hydrolysis) • Phase II (Glucuronidation/Sulfation) Converts lipophilic drug → hydrophilic metabolite 11. Renal & Biliary Elimination • Nephron: Filtration + Secretion − Reabsorption • Biliary excretion & Enterohepatic recycling Total Clearance CL_tot = CL_renal + CL_hepatic 12. Excretion from the Body • Urine (Primary polar metabolite route) • Bile/Faeces, Expired Air, Sweat, Milk Elimination Half-Life t1/2 = (0.693 × Vd) / CL
svg-v339-01-adme-12-step-journey — 8.1 Complete 12-Step Journey of an Orally Administered Drug (ADME): Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

12. Authoritative References, Regulatory Sources & Editorial Disclaimer

Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 08 [8.5] (p. 95)

Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)

Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT

Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.